Texas Diabetes & Endocrinology, P.A.

Academic/Hospital

Also known as: Texas Diabetes and Endocrinology, P.A. - Round Rock | Texas Diabetes & Endocrinology | Texas Diabetes & Endocrinology, P.A. | Texas Diabetes & Endocrinology, P.A. - Austin

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Apr 1, 2013

Last known activity

Jun 4, 2019

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

insulin aspart

Phase 2 (1 own, 0 via acquisition)

sitagliptin

Indications

Studied for

Diabetes Mellitus
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Recent trials (4)

NCT03977727Lead sponsorPhase 3Jun 4, 2019
NCT03977727Reponsible party - principal investigatorPhase 3Jun 4, 2019
NCT03977727Overall official - principal investigatorPhase 3Jun 4, 2019
NCT01819272Overall official - principal investigatorPhase 2Apr 1, 2013

Details

Last known activity: Jun 4, 2019